Godsey & Gibb Inc’s Ingevity NGVT Stock Holding History

Godsey & Gibb Inc’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50	Closed	-$3.52K	–	376
2022 Q4	$3.52K	Buy	+50	New	+$3.52K	﹤0.01%	242

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Godsey & Gibb Inc's NGVT Position: Q1 2023 in Review

Godsey & Gibb Inc sold out of Ingevity (NGVT) in Q1 2023, closing a stake of 50 shares — an estimated $3.52K sold.

Godsey & Gibb Inc first reported a position in NGVT in Q4 2022 and held it in 1 quarter. The position peaked at $3.52K in Q4 2022. 281 funds tracked by Wall St. Rank hold NGVT as of Q1 2023.

Godsey & Gibb Inc reported no remaining Ingevity position as of Q1 2023 after selling out during the quarter.
Godsey & Gibb Inc sold 50 Ingevity shares in Q1 2023, an estimated $3.52K.
Godsey & Gibb Inc first reported a position in Ingevity in Q4 2022 and held it in 1 quarter.
Godsey & Gibb Inc's Ingevity position peaked at $3.52K in Q4 2022.
281 funds tracked by Wall St. Rank held Ingevity as of Q1 2023.

Based on Godsey & Gibb Inc's 13F filing for Q1 2023, filed 18 Apr 2023.